[Investigations of the T and B cells and the hemopexin-carrying lymphocytes in cases of porphyria cutanea tarda (author's transl)].
The immunoglobulins and hemopexin carrying cells have been determined in 14 patients having Porphyria cutanea tarda and in 15 healthy volunteers. At the same time, the stimulating effect of phytohemaglutinine and the leucocytesmigration inhibition by purified tuberculine proteins, were measured. In the 14 cases of Porphyria cutanea tarda, the IgG content and the number of hemopexin carrying lymphocytes was significantly increased, while the amounts of the other immunoglobuline carrying cells, and of T lymphocytes, was unchanged. Phytohemaglutinine stimulation and inhibition of leukocytes migration by purified tuberculine proteins were found to be identical in both patients and control groups.
D000368:Aged; D001402:B-Lymphocytes / Q000276:immunology; D002464:Cell Migration Inhibition; D005260:Female; D006466:Hemopexin / Q000032:analysis*; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D066298:In Vitro Techniques; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011164:Porphyrias / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology
D007136:Immunoglobulins; D006466:Hemopexin
Untersuchung der T- und B-Zellen, sowie der Hämopexin-tragenden Lymphozyten bei Porphyria  cutanea tarda-Kranken